KBC Group’s 10x Genomics TXG Stock Holding History

KBC Group’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$336K	Hold	3,714	–	–	﹤0.01%	858
2026 Q2	$142K	Hold	3,714	–	–	﹤0.01%	1200
2026 Q1	$79K	Sell	3,714 -1,358	-27%	-$27.1K	﹤0.01%	1462
2025 Q4	$83K	Hold	5,072	–	–	﹤0.01%	1406
2025 Q3	$59K	Hold	5,072	–	–	﹤0.01%	1590
2025 Q2	$59K	Hold	5,072	–	–	﹤0.01%	1526
2025 Q1	$44K	Hold	5,072	–	–	﹤0.01%	1815
2024 Q4	$73K	Buy	5,072 +1,847	+57%	+$29.1K	﹤0.01%	1717
2024 Q3	$73K	Buy	3,225 +902	+39%	+$18.6K	﹤0.01%	1498
2024 Q2	$45K	Hold	2,323	–	–	﹤0.01%	1682
2024 Q1	$87K	Buy	2,323 +473	+26%	+$20.8K	﹤0.01%	1205
2023 Q4	$104K	Hold	1,850	–	–	﹤0.01%	1052
2023 Q3	$76K	Buy	+1,850	New	+$96.2K	﹤0.01%	1138
2022 Q4	–	Sell	-850	Closed	-$24K	–	1554
2022 Q3	$24K	Hold	850	–	–	﹤0.01%	1501
2022 Q2	$38K	Sell	850 -5,272	-86%	-$274K	﹤0.01%	1468
2022 Q1	$466K	Hold	6,122	–	–	﹤0.01%	834
2021 Q4	$912K	Buy	6,122 +1,560	+34%	+$239K	﹤0.01%	734
2021 Q3	$664K	Hold	4,562	–	–	﹤0.01%	816
2021 Q2	$893K	Hold	4,562	–	–	﹤0.01%	785
2021 Q1	$826K	Hold	4,562	–	–	﹤0.01%	782
2020 Q4	$646K	Buy	+4,562	New	+$662K	﹤0.01%	820

Other funds holding TXG

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Counterpoint Mutual Funds San Diego, California $1.16B AUM 33.78% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Convergence Investment Partners Palm Beach Gardens, Florida $1.35B AUM 71.9% 1-Year Est. Return

Cookson Peirce & Co Pittsburgh, Pennsylvania $2.77B AUM 64.09% 1-Year Est. Return

KBC Group's TXG Position: Q3 2026 in Review

KBC Group held its 10x Genomics (TXG) position steady in Q3 2026 at 3,714 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #858.

KBC Group first reported a position in TXG in Q4 2020 and has held it in 21 quarters since. The position peaked at $912K in Q4 2021. 157 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

KBC Group held 3,714 shares of 10x Genomics worth $336K as of Q3 2026.
KBC Group left its 10x Genomics share count unchanged in Q3 2026.
10x Genomics made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #858 holding.
KBC Group first reported a position in 10x Genomics in Q4 2020 and has held it in 21 quarters since.
KBC Group's 10x Genomics position peaked at $912K in Q4 2021.
157 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.